CRISPR and Genome Editing – Products

In a significant stride towards advancing nanoparticle drug delivery manufacturing technology, German pharmatech company, leon-nanodrugs GmbH (LEON), proudly announces a pioneering technical evaluation by CMAC, University of Strathclyde.

Breakthrough medium delivers speed and scale to CAR-T cell therapy manufacturers.

Collaboration leverages cutting-edge digital platform to streamline development and manufacturing activities and speed patient access to life-changing treatments.

Enhanced performance and 33% energy savings support quality and sustainability goals in the laboratory.

ERS Genomics Limited announced its patent CN201380038920.6 was upheld by the China National Intellectual Property Administration (CNIPA) in response to an invalidation challenge.

Get higher protein yields from your recombinant antibody expression using the Invitrogen GeneOptimizer algorithm and high-performing Expi expression systems. Outsource all or part of your workflow from in slico sequence to purified protein

This article explores major advances in disease modification for illnesses that still lack effective treatments, as well as some challenges and approaches to overcome them.

Viroclinics-DDL (referred to herein as Cerba Research, the Netherlands), proudly announces changing its name to Cerba Research as of the 1st of April 2024.

ProteoNic Biosciences, announced a partnership with Ginkgo Bioworks (NYSE: DNA). This strategic alliance will grant Ginkgo Bioworks’ customers access to ProteoNic's state of the art vector technology in the field of protein production.

This application note presents a case study where a manual cloning approach was adapted with an automated platform to expedite experiments on 96-well and 384-well plates.